Reviva Pharmaceuticals Holdings, Inc. · NASDAQ:RVPH
UBS Group AG reported a 5.80% stake in Reviva Pharmaceuticals Holdings, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 7, 2026
UBS Group AG reported a 5.80% stake in Reviva Pharmaceuticals Holdings, Inc., 746,095 shares, as a passive investor on Mar 31, 2026. Filed May 7, 2026 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 746,095
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| UBS Group AG | 5.80% | 746,095 |
Source
Related
- Reviva Pharmaceuticals Holdings, Inc.
- UBS Group AG
- Reviva Pharmaceuticals Holdings, Inc. shareholders
- Schedule 13G/A · UBS Group AG · Jul 31, 2026
- Schedule 13G/A · Barclays PLC · Aug 13, 2026
- Schedule 13G/A · Millennium Management LLC · Aug 3, 2026
- Schedule 13G/A · CVI Investments, Inc. · May 15, 2026
- Schedule 13G · Barclays PLC · May 14, 2026
- Schedule 13G · Millennium Management LLC · Mar 30, 2026